logo
MMA welcomes new healthcare posts, repeats call to scrap contract scheme

MMA welcomes new healthcare posts, repeats call to scrap contract scheme

MMA president Dr Kalwinder Singh Khaira said the government should move to abolish the contract employment scheme once there is an adequate number of permanent posts available. (Freepik pic)
PETALING JAYA : The Malaysian Medical Association has welcomed the government's decision to create thousands of new positions for doctors, but called again for the abolition of the long-standing contract doctor system in public healthcare.
This comes after Prime Minister Anwar Ibrahim announced today the government will expedite filling 4,352 healthcare positions, including contract appointments for doctors.
In a statement today, MMA president Dr Kalwinder Singh Khaira described the move as a 'positive and much-needed step forward' in addressing long-standing concerns over the lack of job security and career progression for government doctors.
'It is our hope that these positions will be permanent positions for contract doctors and if so, that the permanent positions will be given based on seniority in terms of years of service,' he said.
Kalwinder said more positions should be created to ensure that every contract doctor currently in the system can eventually be absorbed into permanent roles.
MMA is also urging the government to use this opportunity to reinstate the previous policy of offering permanent posts to all new doctors, in line with practices in other civil service sectors.
'Once an adequate number of permanent posts are available, the government should move on to abolish the contract employment scheme,' he said.
Such a move would not only restore confidence in the public healthcare system but also improve retention rates and morale among doctors, many of whom have left for the private sector or opportunities abroad, he said.
Since 2016, medical graduates undergoing housemanship have been offered contracts instead of permanent jobs because of a glut of medical students.
Despite some improvements after a 2021 strike, many contract doctors still face limited career prospects and leave the public system for better opportunities elsewhere.
From 2017 to 2023, it was reported that a total of 3,046 contract doctors left the civil service.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Poisons Act amended: Expanded powers for police, broader enforcement scope
Poisons Act amended: Expanded powers for police, broader enforcement scope

Malay Mail

timean hour ago

  • Malay Mail

Poisons Act amended: Expanded powers for police, broader enforcement scope

PUTRAJAYA, July 29 — The Dewan Rakyat passed the Poisons (Amendment) Bill 2025 yesterday, signalling the government's continued commitment to curbing the misuse of controlled substances through more robust and inclusive enforcement. In a joint statement today, the Ministry of Health (MOH) and Home Ministry (KDN) said the Bill aims to enhance the effectiveness of enforcement under the Poisons Act 1952, which governs the use, possession, and distribution of poisons and psychotropic substances in Malaysia. 'These amendments are intended to allow for faster, more comprehensive and responsive action in addressing threats to public health and national security,' the ministries said. The Bill was passed by a majority voice vote after being debated by 12 Members of Parliament from both the government and the opposition. Key provisions include expanding enforcement authority to all police officers regardless of rank, and to other officers appointed by the health minister — including those from other ministries or agencies — as needed. Under the current provisions, only three categories of officers have enforcement authority — Drug Enforcement Officers (pharmacists in the public service), police officers ranked Inspector and above, and senior Customs officers. 'However, in practice, patrol and inspection duties are usually carried out by lower-ranked officers such as constables and corporals. Therefore, expanding enforcement powers to all police personnel will improve operational efficiency and coverage,' read the statement. The Bill also addresses enforcement gaps in areas where authorised officers are not present. The health minister is now empowered to appoint other officers, under set terms and conditions, to assist in enforcement when needed. Additional focus has been placed on enhancing officer training, supervision, and coordination of control over listed poisons and prohibited substances, including those found in vape products, to ensure stronger safeguards for both public health and national safety. — Bernama

Health groups seek judicial review on drug price display rule
Health groups seek judicial review on drug price display rule

Free Malaysia Today

time2 hours ago

  • Free Malaysia Today

Health groups seek judicial review on drug price display rule

Medicine price displays at clinics have been mandatory since May 1, although a grace period of three months is in place before the authorities start issuing compounds. (AFP pic) PETALING JAYA : Seven health groups and a general practitioner have applied for leave for judicial review regarding the mandatory drug price displays at private healthcare facilities. The application, filed in the Kuala Lumpur High Court on Thursday, names the domestic trade and cost of living minister, health minister, and government as respondents. The applicants want the rule to be nullified and its enforcement stayed by the court pending the disposal of their judicial review application. They claim that the rule, under Section 10 of the Price Control and Anti-Profiteering Act (Act 723), was gazetted in excess of the authority of the domestic trade and cost of living minister. They contend that Section 10 of the Act cannot apply to drugs administered by health practitioners, which is provided for by Section 19 of the Poisons Act 1952 (Act 366), health news portal CodeBlue reported. They also argue that clinics operated by registered health practitioners cannot be considered to be supplying 'goods and services' under Section 10 of Act 723. 'The administration of medical and dental treatment by professional men is neither sale of goods nor supply of services within the context of the PCAPA 2011. 'As such, charges for medical treatment, including the dispensing of drugs, are not 'prices of drugs' but part of the fees for professional services,' they said in their application. It was filed by the Malaysian Medical Association (MMA), Association of Private Practitioners Sabah, Malaysian Association for the Advancement of Functional and Interdisciplinary Medicine, Organisation of Malaysian Muslim Doctors, Federation of Private Medical Practitioners Associations Malaysia, Malaysian Private Dental Practitioners' Association, Society of Private Medical Practitioners Sarawak, and one Dr Saifulbahri Ahmad. Medicine price displays at clinics have been mandatory since May 1, although a grace period of three months is in place before the authorities start issuing compounds. Under the policy, private healthcare providers are required to clearly display the prices of prescription and over-the-counter medicines, traditional products, and supplements. MMA and other medical groups opposed the policy from the start, saying it should fall under the Private Healthcare Facilities and Services Act 1998 and be delayed pending a review of general practitioners' consultation fees. The applicants also claimed that domestic trade and cost of living minister Armizan Mohd Ali did not 'meaningfully consult' the groups on the rule or respond to their objections. They claimed Armizan did not discuss the rule with health minister Dzulkefly Ahmad to understand why it would burden general practitioners. 'The impugned order therefore suffers from procedural impropriety,' they said.

Doctors seek judicial review to quash Malaysia's drug price display mandate
Doctors seek judicial review to quash Malaysia's drug price display mandate

Malay Mail

time3 hours ago

  • Malay Mail

Doctors seek judicial review to quash Malaysia's drug price display mandate

KUALA LUMPUR, July 29 — Seven medical groups and a Sabah-based general practitioner have filed for judicial review of a government order requiring private clinics to display retail medicine prices, arguing it exceeds ministerial powers and threatens professional medical practice. The judicial review was filed in the Kuala Lumpur High Court last Thursday by the Association of Private Practitioners, Sabah (APPS), the Malaysian Medical Association (MMA), the Malaysian Association for the Advancement of Functional and Interdisciplinary Medicine (Maafim), the Organisation of Malaysian Muslim Doctors (Perdim), the Federation of Private Medical Practitioners Associations Malaysia (FPMPAM), the Malaysian Private Dental Practitioners' Association (MPDPA), the Society of Private Medical Practitioners Sarawak (SPMPS), and a Dr Saifulbahri Ahmad They named Domestic Trade and Cost of Living Minister Datuk Armizan Mohd Ali, Health Minister Datuk Seri Dzulkefly Ahmad, and the federal government as respondents over the Price Control and Anti-Profiteering (Price Marking for Drug) Order 2025, which took effect on May 1, Code Blue reported. The applicants argued that the order was made beyond the minister's legal authority, arguing Section 10 of the Act does not apply to medications administered during treatment as authorised under Section 19 of the Poisons Act 1952. They claimed private medical and dental clinics do not 'supply goods or services' in the way described by the PCAPA and consequently beyond its jurisdiction. Medical and dental treatment is instead a regulated professional process governed by laws such as the Medical Act, Dental Act, Poisons Act, PHFSA, and related regulations, they said. They also contended that dispensing medication is part of treatment following consultation and diagnosis, not a commercial transaction akin to retail sales. The applicants noted that drug labelling is already strictly regulated under PHFSA rules, which require proper labelling, storage, and documentation in both clinics and hospitals. They said if the government intends to regulate treatment costs or prevent profiteering, it should act through the Health Ministry under Sections 106 and 107 of the PHFSA. They warned the order misrepresents the doctor-patient relationship by treating drug dispensation as a retail sale, bypassing the clinical process. The groups also said small GP and specialist clinics would be unfairly disadvantaged, as they cannot match pharmacy chains in pricing due to higher costs and lower purchase volumes. They asked the court to quash the order and stay enforcement pending the outcome of the case, citing potential irreversible harm from prosecutions if the order is later struck down.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store